Skip to main content
profileAnalyst coverage5 yr. financialspremium researchdividendsadv. chartsearningsoptionsprice historyeventsinsiders

Medicines Company News

Dow, S&P 500 and Nasdaq End at Record Highs on Trade-Deal Hopes, Merger Activity

Stocks finished strong Monday as all three major indexes ended at records, boosted by trade optimism and a wave of merger deals.

Novartis Reaches $9.7 Billion Deal to Buy Cholesterol Drug Maker Medicines Co.

Medicines Co. shares hit a record high Monday after the cholesterol drug maker reached a $10 billion takeover deal with Swiss pharmaceutical giant Novartis AG.

Tiffany, Schwab, Novartis, 'Frozen 2,' Jerome Powell - 5 Things You Must Know

U.S. stock futures rise as trade optimism and a mini-wave of merger deals boosts market sentiment; France's LVMH agrees to buy the U.S. jeweler Tiffany for $16.2 billion; Novartis reaches a deal to buy cholesterol drugmaker Medicines Co. for $9.7 billion; Disney's 'Frozen 2' makes $127 million domestically in its weekend debut.

Dow Futures Extend Gains, Global Stocks Bounce as Trade Optimism Lifts Sentiment

U.S. equity futures jumped higher Monday, pulling all three major benchmarks back towards all-time peaks, as investors added to bets of a near-term trade pact between Washington and Beijing and reacted to a mini-wave of merger deals that boosted market sentiment around the world.

Novartis to Swallow Up The Medicines Company for $9.7 Billion

Novartis said its main target in the buy was The Medicines Company's specialty cholesterol drug inclisiran that performed well in late-stage clinical trials.

Breaking News

Tesla Q2 Deliveries Slump To 254,695 As Shanghai Shutdown, Supply Chain Snarls Take Toll

Tesla said it had a record rate of production in June, but supply chain disruption and the closure of its Shanghai gigafactory triggered a slump in Q2 deliveries.

Summers, Others Cite Growing Chance of Recession

GDP shrank an annualized 1.6% in the first quarter, and some experts anticipate another drop in the second quarter.

Coinbase Faces A New Scandal

The platform denies selling proprietary customer data and announces it is expanding into several European countries.